TNM classification of thyroid carcinoma

Area of Science:

• Oncology
• Endocrinology
• Surgical Oncology

Background:

• Understanding of well-differentiated thyroid cancer has advanced, emphasizing prognostic factors and risk stratification for improved patient management.
• Risk group stratification is critical for determining the prognosis and guiding treatment strategies in thyroid cancer patients.

Purpose of the Study:

• To review the TNM staging system for thyroid cancer, focusing on its adherence to tumor biology and recent revisions.
• To highlight the importance of the TNM staging system in standardizing data reporting and facilitating international comparison of thyroid cancer outcomes.

Main Methods:

• Review of the TNM staging system (6th edition, 2002) for thyroid cancer, based on retrospective data analysis.
• Analysis of key prognostic factors incorporated into the TNM system, including age, tumor size, extrathyroidal extension, and lymph node involvement.

Main Results:

• The TNM staging system incorporates age (below/above 45) as a key prognostic factor.
• Tumor characteristics like size (T1 < 2 cm), extrathyroidal extension (T3), and resectability (T4a) are defined.
• Nodal staging includes N1a (level VI nodes) and N1b (level IV, mediastinal, contralateral nodes).

Conclusions:

• Revisions to the TNM staging system align with current thyroid cancer management and adjuvant therapy philosophies.
• The TNM system facilitates standardized data reporting and global comparison of thyroid cancer research.
• Despite its utility, the TNM system for thyroid cancer currently lacks Level I evidence.